KLOW

Sold by case = 10 vials

KLOW Protocol

For Research Use Only. Not for Human or Veterinary Consumption.

The KLOW Protocol is a combination peptide therapy stack designed for laboratory research into tissue regeneration and repair. It includes TB-500, a peptide studied for actin regulation and cell migration; BPC-157, investigated for angiogenesis and extracellular matrix remodeling; GHK-Cu, researched for collagen synthesis and antioxidant effects; and KPV, explored for its anti-inflammatory properties. This combination supports comprehensive studies into cellular regeneration, inflammation modulation, and skin and tissue repair mechanisms.

This product is intended exclusively for qualified laboratory research. Not approved for therapeutic, diagnostic, or human use.

Mechanism of Action

• TB-500: Studied for modulating actin cytoskeleton dynamics to facilitate cell migration and tissue remodeling.

• BPC-157: Investigated for promoting angiogenesis and extracellular matrix remodeling in tissue repair models.

• GHK-Cu: Explored for its role in collagen synthesis, antioxidant activity, and cellular regeneration.

• KPV: Researched for anti-inflammatory effects and modulation of immune responses in laboratory settings.